(Press Enter)
Because our logistics operation is fully outsourced and uses logistics service providers for warehousing and transportation, sustainability is embedded into our vendor management process. We encourage our vendors to make changes that can add efficiency to product transportation and actively review their sustainability scores during the selection process.
Whether ground, air or ocean, the mode of transport of our products plays a meaningful role in developing our transportation plans. Wherever it is feasible and makes sense, we move from air to ocean transport, which significantly cuts carbon emissions, and utilize vendors who provide more efficient ground transportation. Some are even beginning to offer electric fleet vehicles.
All of our products are shipped in temperature-controlled containers. Our biology-based therapies Opdivo, Orencia, Empliciti, Yervoy and Nulojix require cold-chain transport and must remain at a constant temperature (2–8 degrees C) from the time they leave the manufacturing facility to when they reach the patient. That’s why we ship these almost exclusively in battery-operated refrigerated pallet-sized containers that are completely reusable. When we have smaller, parcel-sized shipments, we use passive refrigeration in insulated shipper boxes with gel-pack inserts. Currently, we use reusable parcel containers in Puerto Rico, Mexico and Canada and aim to expand their use in other markets where possible in coming months.
Converting air cargo to ocean cargo =
improvement in carbon footprint per
transportation container.
Ultimately, bolstering our supply chain’s reliability, agility and sustainability is a priority for us, and we will continue to work with vendors who share our commitment to continuing to reduce our transportation-related environmental impacts.
